CARLA TERRELL: Open Payments
NPI 1053954073 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,789 in 73 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $212 · 2025 $1,789
Food & beverage: $1,704Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $318 |
| PFIZER INC. | 11 | $186 |
| Sumitomo Pharma America, Inc. | 6 | $159 |
| 180 Medical, Inc. | 6 | $144 |
| Endo USA, Inc. | 5 | $133 |
| ABBVIE INC. | 6 | $108 |
| UROGEN PHARMA, INC. | 4 | $105 |
| IMMUNITYBIO, INC. | 4 | $97 |
| C. R. Bard, Inc. & Subsidiaries | 4 | $91 |
| SEAGEN INC. | 1 | $85 |
Products named: XTANDI, ERLEADA, RYBREVANT, GEMTESA, ANKTIVA, JELMYTO, AVEED, BOTOX.
Industry payments across KY — which companies pay providers there.
